Parts of this article (those related to clinical trial phase III) need to be updated.September 2016)(
Cevira is in development as a local treatment for Cervical intraepithelial neoplasia lesions and human papilloma virus (HPV) of the cervix without damaging healthy tissue. With Cevira, Photocure aims to develop the first non-surgical treatment for precancerous cervical lesions using photodynamic therapy (PDT). Cevira treatment is administered locally and remains in contact with the cervix to deliver treatment for up to 24 hours. A cup holds the ointment against the cervix for initial absorption. After a few hours, a light source within the cup emits light at a specific wavelength so the Active Pharmaceutical Ingredient, hexylaminolevulinate (HAL), react with the tissue.
- "Photodynamic Device Developed to Treat Precancerous Cervical Lesions". Medical Advice Network. 18 March 2011. Retrieved 2013-06-06.
- Fontanazza, Maria (April 18, 2011). "Drug and Light Join Forces to Fight Precancerous Lesions". MDDI. Retrieved 2013-06-06.